Corporate Actions

Back

Emcure Pharmaceuticals faces Rs 57.74 crore in penalty orders from the Income-tax Department

02-Oct-26 21:48 Hrs IST

Emcure Pharmaceuticals Limited has disclosed receiving penalty orders totaling Rs 57,73,96,732 from the Income-tax Department related to financial years 2014-15 through 2020-21 (assessment years 2015-16 to 2021-22), as revealed in documents submitted to the National Stock Exchange of India Limited and BSE Limited on October 2, 2026. The company is currently evaluating legal options, including filing an appeal before the Appellate Authority, in response to these orders which stem from ongoing litigations previously disclosed in governance reports up to the quarter ended June 30, 2026.

Attention Investors:

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. || KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. || No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.